Today’s Top Three in Pharma 060109 posted on June 1, 2009Novartis' Reclast gets approval for osteoporosis prevention in post-menopausal women - Reclast® (zoledronic acid 5 mg) Injection[*] has been approved by the US Food and Drug Administration (FDA) as …Continue Reading about Today’s Top Three in Pharma 060109 →